Antismoking agents do not contribute synergistically to semaglutide’s ability to reduce alcohol intake in rats

Preclinical studies have identified glucagon-like peptide-1 receptor (GLP-1R) agonists, and the antismoking agents varenicline and bupropion as tentative agents for treatment of alcohol use disorder (AUD). Combining different medications is a recent approach that has gained attention regarding heter...

Descripción completa

Detalles Bibliográficos
Autores principales: Aranäs, Cajsa, Blid Sköldheden, Sebastian, Jerlhag, Elisabet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500129/
https://www.ncbi.nlm.nih.gov/pubmed/37719854
http://dx.doi.org/10.3389/fphar.2023.1180512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500129/
https://www.ncbi.nlm.nih.gov/pubmed/37719854
http://dx.doi.org/10.3389/fphar.2023.1180512

Ejemplares similares